Needle Free Technologies the Preferred Choice for Patients Market Surging at 14.3% CAGR

February 13, 2015

Wellesley, Mass., February 13, 2015 –BCC Research ( reveals in its new report on needle free technologies that during the past several decades, tremendous progress has been made toward the development of safe, effective and convenient means of drug administration. Advances have been possible  because of increasing awareness about health concerns associated with traditional needle-based drug delivery devices and technological innovations to meet the current challenges.

Rising cases of needlestick injuries and the transmission of blood-borne diseases is largely responsible for the growing concern regarding needle-based drug delivery devices. Needle-free drug delivery devices are considered as an effective alternative and novel technique to introduce drugs into a patient’s body without invading the skin with a needle. It is growing in popularity and has received considerable attention during the past few years primarily due to being painless, effective and a safe drug delivery method. Needle-free drug delivery devices typically include needle-free injectors, inhalers, transdermal patches and other devices based on novel needle technologies (e.g., microneedles and advanced pen needles).

The global market for needle-free technologies was worth nearly $963.6 million in 2013. The market is expected to increase from $1.1 billion in 2014 to $2.1 billion by 2019, at a compound annual growth rate (CAGR) of 14.3%. Evolving market dynamics and growing interest toward safe, effective and advanced needle-free drug delivery technologies are the major drivers of this market.

“The goal of modern needle-free drug delivery techniques is to increase the prescribing and adoption of important drugs that require self-injection, such as biologics,” says BCC Research analyst Dr. Ritu Thakur. “Continuous innovation and availability of newer needle-free drug delivery systems have the potential to be enabling for highly viscous drug products that cannot be delivered by the traditional needle and syringe, adding to the utility of the technology.”

As more companies begin to recognize the benefits, needle-free injection technology will continue to grow in popularity, both among patients and physicians, and ultimately increase adoption of injectable drug therapies.

Needle-Free Devices, Technologies and Global Markets focuses on some key developments in the field of drug delivery, especially those that deal with the development of painless, patient-friendly alternatives to injections for the delivery of macromolecules. The study includes information about significant products, players, issues and trends, and other information affecting the needle-free drug delivery industry.


To Contact us, click here  help

Source: BCC Research

Editors and reporters who wish to speak with the analyst should contact Steven Cumming at


Needle-Free Devices, Technologies and Global Markets( HLC178A )
Publish Date: Dec 2014    

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email or visit to request access to our library of market research.